BioVie (BIVI) Stock Chart & Stock Price History $1.85 -0.02 (-1.07%) As of 12:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioVie Stock Price Performance The BioVie (BIVI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.46%, with a year-to-date return of -90.75%. In the past month, the stock has increased 16.35%, reflecting recent market activity. As of the latest close, BioVie traded at $1.87 with a market cap of $14.08 million and volume of 256,861 shares. Receive BIVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.07%1 Month Performance+16.35%3 Month Performance-83.03%Year-To-Date Performance-90.75%1 Year Performance-93.46% BIVI Stock Chart for Friday, September, 19, 2025 BIVI Chart by TradingView BioVie Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/18/2025$1.82$1.87+2.75%$1.95$1.84256,861 shs$14.08 million09/17/2025$1.84$1.82-0.82%$1.95$1.82256,395 shs$13.71 million09/16/2025$1.76$1.84+4.26%$1.84$1.72136,676 shs$13.83 million09/15/2025$1.87$1.76-5.88%$1.92$1.75253,094 shs$13.25 million09/12/2025$1.88$1.87-0.53%$2.03$1.85575,225 shs$14.08 million09/11/2025$1.91$1.88-1.57%$2.00$1.86335,183 shs$14.16 million09/10/2025$1.79$1.91+6.70%$1.94$1.78734,381 shs$14.39 million09/09/2025$1.80$1.79-0.56%$1.85$1.69338,670 shs$13.48 million09/08/2025$1.74$1.80+3.45%$1.85$1.67276,410 shs$13.55 million09/05/2025$1.59$1.74+9.43%$1.77$1.56412,483 shs$13.10 million Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 09/04/2025$1.67$1.59-4.79%$1.69$1.54204,321 shs$11.98 million09/03/2025$1.58$1.67+5.70%$1.69$1.59501,283 shs$12.58 million09/02/2025$1.52$1.58+3.95%$1.65$1.52425,831 shs$11.90 million09/01/2025$1.52$1.52$1.55$1.42228,238 shs$11.45 million08/29/2025$1.48$1.52+2.70%$1.55$1.42228,238 shs$11.45 million08/28/2025$1.62$1.48-8.64%$1.64$1.46355,666 shs$11.14 million08/27/2025$1.58$1.62+2.53%$1.64$1.56159,899 shs$12.20 million08/26/2025$1.65$1.58-4.24%$1.68$1.56201,232 shs$11.90 million08/25/2025$1.60$1.65+3.12%$1.67$1.56208,652 shs$12.42 million08/22/2025$1.52$1.60+5.26%$1.65$1.52187,117 shs$2.98 million08/21/2025$1.56$1.52-2.56%$1.57$1.46263,112 shs$2.83 million08/20/2025$1.59$1.56-1.89%$1.59$1.49175,544 shs$2.90 million08/19/2025$1.75$1.59-9.14%$1.80$1.57323,243 shs$2.96 million08/18/2025$1.65$1.75+6.06%$1.80$1.62308,353 shs$3.26 million Related Companies Karyopharm Therapeutics Stock Chart NRx Pharmaceuticals Stock Chart PDS Biotechnology Stock Chart Precision BioSciences Stock Chart Elutia Stock Chart Genenta Science Stock Chart ImmuCell Stock Chart INmune Bio Stock Chart Relmada Therapeutics Stock Chart Liminatus Pharma Stock Chart Receive BIVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIVI) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
